Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cipta Sarana Medika Tbk. (DKHH) vs Phapros Tbk. (PEHA) Price & Performance

Cipta Sarana Medika Tbk.Trade
Phapros Tbk.Trade

Price performance (Past 24H)

Key statistics

Cipta Sarana Medika Tbk. vs Phapros Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 19.96M 24h volume), while Phapros Tbk. trades at Rp256 (market cap 215.04B, 7.3K 24h volume). The key difference: Phapros Tbk. is the larger of the two by market cap, and Cipta Sarana Medika Tbk. is more actively traded (19.96M versus 7.3K). Which is the better fit depends on your goals.

DKHHPEHA
Market Cap
160.67B215.04B
Volume
19.96M7.3K
Lot
199.6K73
Turnover
1.3B1.88M
Average Price
65.32256.96
Value
1.3B1.88M
Indicative Equilibrium Price
64258
Indicative Equilibrium Volume
1.35K16

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DKHH
View details
PEHA
View details

About Cipta Sarana Medika Tbk.

PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.

Read more on DKHH

About Phapros Tbk.

PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.

Read more on PEHA